All Stories

  1. Epilepsy and associated mortality in patients with multiple sclerosis
  2. Familial aggregation and heritability of type 1 diabetes mellitus and coaggregation of chronic diseases in affected families
  3. Graft outcomes following immunosuppressive therapy with different combinations in kidney transplant recipients: a nationwide cohort study
  4. Familial aggregation of Parkinson’s disease and coaggregation with neuropsychiatric diseases: a population-based cohort study
  5. Efficacy and Safety of Apixaban, Dabigatran, Rivaroxaban, and Warfarin in Asians With Nonvalvular Atrial Fibrillation
  6. Familial aggregation of myasthenia gravis in affected families: a population-based study
  7. Epidemiology of Anaphylactic Shock and its Related Mortality in Hospital Patients in Taiwan
  8. Maternal and fetal outcomes of pregnant women with type 1 diabetes, a national population study
  9. Association Between Use of Non–Vitamin K Oral Anticoagulants With and Without Concurrent Medications and Risk of Major Bleeding in Nonvalvular Atrial Fibrillation
  10. Familial aggregation of nasopharyngeal carcinoma in Taiwan
  11. Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan
  12. Cardiovascular disease risk in patients receiving organ transplantation: a national cohort study
  13. Association of a Family History of Atrial Fibrillation With Incidence and Outcomes of Atrial Fibrillation
  14. Nationwide cohort study on the epidemiology and survival outcomes of thyroid cancer
  15. Epidemiology and survival outcome of breast cancer in a nationwide study
  16. Gout: Risk of premature death in gout unchanged for years
  17. Familial aggregation of rheumatoid arthritis and co-aggregation of autoimmune diseases in affected families: a nationwide population-based study
  18. Familial Aggregation and Heritability of Congenital Heart Defects
  19. Familial Aggregation and Heritability of Schizophrenia and Co-aggregation of Psychiatric Illnesses in Affected Families
  20. Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected families
  21. Impact of gout on the risk of atrial fibrillation
  22. Familial Aggregation of Systemic Lupus Erythematosus and Coaggregation of Autoimmune Diseases in Affected Families
  23. Effect of allopurinol on all-cause mortality in adults with incident gout: propensity score–matched landmark analysis
  24. Global epidemiology of gout: prevalence, incidence and risk factors
  25. Familial Risk of Sjögren's Syndrome and Co‐aggregation of Autoimmune Diseases in Affected Families: A Nationwide Population Study
  26. Epidemiology and management of gout in Taiwan: a nationwide population study
  27. Eligibility for and Prescription of Urate-Lowering Treatment in Patients With Incident Gout in England
  28. Hyperthyroid and Hypothyroid Status Was Strongly Associated with Gout and Weakly Associated with Hyperuricaemia
  29. Comorbidities in patients with gout prior to and following diagnosis: case-control study
  30. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study
  31. Familial aggregation of gout and relative genetic and environmental contributions: a nationwide population study in Taiwan
  32. Survival impact of serum uric acid levels in children and adolescents
  33. Increased risk of cancer among gout patients: A nationwide population study
  34. Risk of end-stage renal disease associated with gout: a nationwide population study
  35. Elevated risk of mortality among gout patients: A comparison with the National Population in Taiwan
  36. Gout: an independent risk factor for all-cause and cardiovascular mortality
  37. Rare copresent rheumatoid arthritis and gout: comparison with pure rheumatoid arthritis and a literature review